Biocorrx (OTCMKTS:BICX) vs. Agilon Health (NYSE:AGL) Critical Contrast

Biocorrx (OTCMKTS:BICXGet Free Report) and Agilon Health (NYSE:AGLGet Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Earnings & Valuation

This table compares Biocorrx and Agilon Health”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Biocorrx $10,000.00 890.46 -$5.11 million ($0.35) -1.26
Agilon Health $6.06 billion 0.05 -$260.15 million ($0.77) -1.03

Biocorrx has higher earnings, but lower revenue than Agilon Health. Biocorrx is trading at a lower price-to-earnings ratio than Agilon Health, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Biocorrx and Agilon Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biocorrx N/A N/A -130.26%
Agilon Health -5.35% -66.76% -17.47%

Risk & Volatility

Biocorrx has a beta of 0.05, meaning that its share price is 95% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 0.07, meaning that its share price is 93% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations and price targets for Biocorrx and Agilon Health, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biocorrx 0 1 0 0 2.00
Agilon Health 2 13 4 0 2.11

Agilon Health has a consensus price target of $2.81, indicating a potential upside of 253.61%. Given Agilon Health’s stronger consensus rating and higher possible upside, analysts clearly believe Agilon Health is more favorable than Biocorrx.

Summary

Agilon Health beats Biocorrx on 7 of the 12 factors compared between the two stocks.

About Biocorrx

(Get Free Report)

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

About Agilon Health

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.